Ingredients | Amount Per Serving |
---|---|
(4:1)
|
1000 mg |
Below is general information about the effectiveness of the known ingredients contained in the product Red Tea Rooibos 4:1 Extract Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Red Tea Rooibos 4:1 Extract Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when used orally in food amounts (6,4120). There is insufficient reliable information available about the safety of rooibos when used orally in medicinal amounts.
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Red Tea Rooibos 4:1 Extract Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Theoretically, taking rooibos with ACEIs may increase the therapeutic and adverse effects of ACEIs.
Details
Clinical research in healthy adults shows that taking a single dose of rooibos tea, 400 mL orally, inhibits angiotensin-converting enzyme activity (101253).
|
Theoretically, taking rooibos with atorvastatin may increase the therapeutic and adverse effects of atorvastatin.
Details
Animal research shows that consuming green rooibos extract with atorvastatin daily for 3 weeks increases the maximum plasma concentration of atorvastatin by 6-fold and reduces the clearance of atorvastatin (104211).
|
Theoretically, taking rooibos with CYP1A2 substrates may increase the effects of CYP1A2 substrates.
Details
In vitro research shows that the methanol extract of rooibos leaves and stems inhibits CYP1A2 enzyme activity (101251).
|
Theoretically, taking rooibos with CYP2C19 substrates may increase the effects of CYP2C19 substrates.
Details
In vitro research shows that the methanol extract of rooibos leaves and stems strongly inhibits CYP2C19 enzyme activity (101251).
|
Theoretically, taking rooibos with CYP2C9 substrates may increase the effects of CYP2C9 substrates.
Details
In vitro research shows that the methanol extract of rooibos leaves and stems inhibits CYP2C9 enzyme activity (101251).
|
Theoretically, taking rooibos with CYP2D6 substrates may increase the effects of CYP2D6 substrates.
Details
In vitro research shows that the methanol extract of rooibos leaves and stems inhibits CYP2D6 enzyme activity (101251).
|
Theoretically, taking rooibos with CYP3A4 substrates may increase the effects of CYP3A4 substrates.
Details
In vitro research shows that the methanol extract of rooibos leaves and stems strongly inhibits CYP3A4 enzyme activity (101251).
|
Below is general information about the adverse effects of the known ingredients contained in the product Red Tea Rooibos 4:1 Extract Powder. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...There is currently a limited amount of information on the adverse effects of roobios.
A thorough evaluation of safety outcomes has not been conducted.
Serious Adverse Effects (Rare):
Orally: Hepatotoxicity.
Hepatic ...Orally, large and long-term doses of rooibos tea might cause hepatotoxicity in some susceptible patients. In a case-report, a 37-year-old man drinking 10 cups of rooibos tea daily for over a year presented with hepatic dysfunction and thrombocytopenia (101254).